Feasibility study of S-1 and CDDP chemotherapy with short hydration for advanced Gastric Cancer
Phase 2
- Conditions
- advanced and/or recurrent gastric cancer
- Registration Number
- JPRN-UMIN000007409
- Lead Sponsor
- PO Japan Southwest Oncology Research Support Organization (JSWOG)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Patient with administration contraindication of S-1 or CDDP (2,3,4,5) pts with active co-morbidities including severe conditions of heart diseases, gastric ulcers, infections, ileus, uncontrollable diabetes, hypertension, renal failure, hepatic cirrhosis, active interstitial. (6) Symptomatic pleural effusion or ascites (7) metastasis to the brain (8) Watery diarrhea (9) Symptomatic psychological disease (10)Concomitant therapy with flucytocine or phenytoin (11)Pregnancy or breast feeding (12)Decision as ineligible by principal investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety
- Secondary Outcome Measures
Name Time Method